Recent Articles from GlobeNewswire

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) --

Appointment adds board governance and operating leadership as Terra advances NRC licensing, FOAK deployment, and commercialization of SOLO

Tel Aviv, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) (“Alarum” or the “Company”) today issued the following statement in response to recent reports regarding their proxy network operations.

BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on July 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 71,200 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 15,150 shares of Vor Bio’s common stock to 7 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).        

MEXICO CITY, July 02, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO, “Aeroméxico”) reports its June 2026 operational results:

On 12 May 2026, the annual general meeting of Equinor ASA (OSE: EQNR, NYSE: EQNR) resolved to reduce the company's share capital by NOK 415,146,180.00 from NOK 6,392,018,780.00 to NOK 5,976,872,600.00 through cancellation and redemption of a total of 166,058,472 shares.

PHILADELPHIA, PA, July 02, 2026 (GLOBE NEWSWIRE) -- Osprey Acquisition Corp. III (NASDAQ:OSPRU) (the “Company”) today announced the closing of its initial public offering of 30,015,000 units, which includes 3,915,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $300,150,000.

VANCOUVER, British Columbia, July 02, 2026 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) will publish its second quarter 2026 operating and financial results on Wednesday, August 5, 2026, after market close. The Company will host a conference call to discuss the results on Thursday, August 6, 2026 at 11:30am Eastern time (8:30am Pacific time). A results presentation will be available for download via the webcast link and in the Presentations section of the Company's website on the day of the conference call.

No Stockholder Action Required at This Time

MONTRÉAL, July 02, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) notes that today, its operating partner, Agnico Eagle Mines Limited (“Agnico Eagle”), reported that a rock mass movement occurred on July 1, 2026, along the north wall of the Barnat open pit at the Canadian Malartic Complex (“Canadian Malartic”) in Québec, Canada. There were no injuries, equipment damage or environmental impact as a result of the event. As a precautionary measure, Agnico Eagle has temporarily suspended mining operations in the Barnat open pit. Agnico Eagle’s technical teams are conducting a detailed geotechnical assessment to confirm the stability of the affected area and determine the appropriate path forward. Planning activities are underway to support the safe and orderly resumption of operations in the Barnat pit.

TORONTO, July 02, 2026 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (TSX: K; NYSE: KGC) (the “Company”) will release its financial statements and operating results for the second quarter of 2026 on Wednesday, July 29, 2026, after market close. On Thursday, July 30, 2026, at 8:00 a.m. EDT Kinross will hold a conference call and audio webcast to discuss the results, followed by a question-and-answer session. The call-in numbers are as follows:

New Partnership Gives Producers a Direct Line to Report Costly Regulations and Advance Lasting Reform

FORT LAUDERDALE, Fla., July 02, 2026 (GLOBE NEWSWIRE) -- ITG, Inc. (Nasdaq: ITG) (“ITG” or the “Company”), a leading provider of end-to-end services to the communications and digital infrastructure industries, today announced the closing of its initial public offering (the “offering”) of 22,439,025 shares of its Class A common stock (the “Common Stock”), which included an additional 2,926,829 shares of Common Stock following the exercise in full of the underwriters’ option to purchase additional shares of Common Stock from the Company, at a price to the public of $16.00 per share. The shares of Common Stock began trading on the Nasdaq Global Select Market on July 1, 2026, under the ticker symbol “ITG.”

PHILADELPHIA, July 02, 2026 (GLOBE NEWSWIRE) --

Independence, Ohio, July 02, 2026 (GLOBE NEWSWIRE) -- Redwood Living, Inc. has been recognized with three Top Workplaces awards for 2026, earning distinction as a Northeast Ohio Top Workplace, a Real Estate Industry Top Workplace and a Compensation & Benefits Top Workplace. 

AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed to maintain CPT® Code 64568, the procedure code used for the Vivistim® procedure, under the New Technology Ambulatory Payment Classification (APC) 1580 for calendar year (CY) 2027, with an associated hospital outpatient payment rate of approximately $45,000, unchanged from the CY 2026 rate. CMS is expected to publish the final Hospital Outpatient Prospective Payment System (OPPS) rule in November of this year, with any changes taking effect January 1, 2027.

ST. JOHN'S, Newfoundland and Labrador, July 02, 2026 (GLOBE NEWSWIRE) --

AUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Ethos Technologies Inc. (NASDAQ: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it will release its financial results for the second quarter of 2026, which ended June 30, 2026, following the close of U.S. financial markets on Monday, August 3, 2026. The company’s earnings press release will be made available on the Ethos Investor Relations website at investors.ethos.com.

Three-year Term to Begin July 1, 2026

SOUTH SAN FRANCISCO and SAN DIEGO, July 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2026 (the “Grant Date”), ORIC granted a total of 44,400 non-qualified stock options and 7,200 restricted stock units to three new non-executive employees who began their employment with ORIC in June 2026.

INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG) announced today that it will release financial results for the quarter ended June 30, 2026, before the market opens on Thursday, July 30, 2026. KRG will conduct a conference call to discuss its financial results on Thursday, July 30, 2026 at 12:00 p.m. Eastern Time.

SAN FRANCISCO, July 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to eight new employees to purchase an aggregate of 215,800 shares of the Company's common stock, effective as of July 1, 2026. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).

EDMONTON, Alberta, July 02, 2026 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) will release its 2026 second quarter results before the markets open on July 29, 2026. A conference call and webcast to discuss the results will be held the same day at 9:00 a.m. MT (11:00 a.m. ET).

INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG) (the “Company”) announced today that its operating partnership, Kite Realty Group, L.P. (the “Operating Partnership”), has closed its previously announced offering (the “Offering”) of $345 million aggregate principal amount of 3.25% exchangeable senior notes due 2032 (the “Notes”), which includes $45 million aggregate principal amount of Notes issued pursuant to the full exercise by the initial purchasers of their overallotment option. The Notes were sold in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Atlanta, GA, July 02, 2026 (GLOBE NEWSWIRE) -- Piedmont Realty Trust (NYSE: PDM) announced today that the Company will release its second quarter financial results on Tuesday, July 28, 2026, after the close of trading on the New York Stock Exchange. A conference call is scheduled for Wednesday, July 29, 2026, at 9:00 a.m. ET and will be broadcast live in listen-only mode on the company’s investor relations website. During the conference call, the Company’s management team will review second quarter performance, discuss recent events, and conduct a question-and-answer period.

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) --

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

Patria SOF V exceeds its initial USD 500m target, building on the success of its predecessor secondary funds

SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company’s Inducement Plan, as a material inducement to employment with the Company, for one recently hired executive employee and two recently hired non-executive employees, each of whom was not previously an employee or director of the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not made under a stockholder approved equity plan.

MENLO PARK, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after market close. Robinhood will host a video call with Chairman & Chief Executive Officer Vlad Tenev and Chief Financial Officer Shiv Verma to discuss its results at 2:00 PM PT / 5:00 PM ET on the same day. The video call and supporting materials will be available at investors.robinhood.com. The event will also be live streamed to YouTube and X.com via Robinhood’s official channels, @RobinhoodApp, and within the Robinhood mobile app. Following the call, a replay and transcript will be available at investors.robinhood.com.

WILMINGTON, Del., July 02, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 981,243 shares of the Company’s common stock to seven newly-hired non-executive employees under the Company’s 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of June 30, 2026 (the “Effective Date”). The inducement grants were previously approved by the Compensation Committee of the Company’s Board of Directors, as a material inducement to the new employees’ entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).The options have an exercise price of $2.03 per share, which is equal to the closing price of the Company’s common stock on the Effective Date. The options have a ten year term, with 25% vesting on the first anniversary of the Effective Date and the remaining 75% vesting in 36 equal monthly installments thereafter. The options are subject to the terms and conditions of the Inducement Plan approved by the Company’s Board of Directors in March 2026 and the terms and conditions of award agreements covering the grants.

BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on July 1, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 951 shares of its common stock to five new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

VANCOUVER, British Columbia and BOSTON, MA, July 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to four new non-officer employees consisting of an aggregate of 20,200 share options and 11,850 restricted share units (RSUs). All of the foregoing share options and RSUs were approved by the Compensation Committee of the Company’s Board of Directors with an effective date of July 1, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK and WALTHAM, Mass., July 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on July 1, 2026, to five newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).

NAARDEN, The Netherlands and MIAMI, July 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 28,700 of NewAmsterdam’s ordinary shares to four non-executive new hires. The share options were granted as an inducement material to the employees’ acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).

BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of inducement equity awards to three newly hired non-executive employees as a material inducement to commencing their employment with the Company.

Daix (France), New York City (New York, United States), July 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the results of the votes of its Combined Shareholders’ Meeting. 

IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification.

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) --

Blood center asks donors to step forward to maintain strong and stable blood inventories

DSI Holding GmbH announces successful outcome of written procedure

Premium Reformer Pilates Brand Debuts in Indonesia with Menteng Opening, Four Additional U.S. Locations on the Horizon

Honoring the Trailblazers, Builders, and Leaders Who Have Strengthened America Across 250 Years of Independence

Five iconic American brands to remove artificial preservatives, colors and flavors by 2028

CHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares of its common stock in the open market at an average price of approximately $0.1956 per share, extending the buyback activity it began this week.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In MongoDB (MDB) To Contact Him Directly To Discuss Their Options

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- If you purchased or acquired PicPay Class A common stock in and/or traceable to PicPay’ January 30, 2026 initial public offering (“IPO”) and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

EMERYVILLE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- NMI Holdings, Inc., (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its second quarter ended June 30, 2026 after the market close on Thursday, July 30, 2026.

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- If you purchased or acquired (a) BitGo Class A common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s January 22, 2026 initial public offering (the “IPO” or “Offering”); and/or (b) BitGo securities between January 22, 2025 and May 13, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

If you purchased or acquired Graphic Packaging securities between February 4, 2025 and February 2, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.

Recognized for Ability to Execute and Completeness of Vision

If you purchased or acquired Commvault securities between April 29, 2025 to January 26, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Hyliion Holdings Corp (AMEX: HYLN) ("Hyliion" or the "Company") for potential violations of the federal securities laws.

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) (“EquipmentShare” or the “Company”) for potential violations of the federal securities laws.

Event expands to three expo days with new packaging pavilion, enhanced networking spaces, and personalized education format

Cerezen™, a non-drug treatment, improved both memory and independent functioning. Results persisted for 1 year and are cost-effective

South Asia's first Bitget Wallet Card links self-custody with global acceptance, offering up to 3% cashback

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 2, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the coverage and future reimbursement by U.S. Medicare for NASHnext®, a non-invasive blood test available through Labcorp, a global leader of innovative and comprehensive laboratory services. This will support large-scale adoption and additional revenue for GENFIT.

Hostinger Ecommerce offers sellers a commerce backend that exists outside any single platform

Invitation: Q2 2026 Results Release and Conference CallThursday, July 30th, 2026

WASHINGTON, D.C., July 02, 2026 (GLOBE NEWSWIRE) -- The United States Mint (Mint) will begin accepting orders for the 2026 Morgan Reverse Proof Silver Dollar and 2026 Peace Reverse Proof Silver Dollar on Thursday, July 9 at noon EDT. There is a household order limit of 10 per product option for the first 24 hours from the on-sale date and time. The production limit for each coin is 250,000.

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Helen of Troy Limited (“Helen of Troy” or “the Company”) (NASDAQ: HELE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

CHARLOTTE, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Cumberland Farms Limited (“Cumberland Farms”) today announced that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Cumberland Farms has applied to list its ordinary shares on the Nasdaq Global Select Market under the ticker symbol “CMBY.”

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property.

San Francisco, July 02, 2026 (GLOBE NEWSWIRE) -- Tripo AI announced this month that it has completed its Series A3 financing round, raising $150 million.The round brought together a broad group of strategic and financial investors across the automotive, gaming, internet, and technology sectors. Automotive backers included Geely Capital among other strategic investors. Gaming companies 4399 Network, Tanwan, and Giant Network also took part, alongside strategic investors Fosun Capital and Orinno Capital. Financial investors CoStone Capital, Addor Capital, T-Capital, and Muhua Tech Ventures joined as well. Existing shareholders INCE Capital and Genesis Capital further increased their investments, underscoring their continued confidence in Tripo AI's strategic direction and long-term growth prospects.The breadth of the investor base reflects growing cross-sector recognition of Tripo AI's leadership in 3D foundation models and world model technologies. These technologies are expected to play an increasingly important role in intelligent manufacturing, interactive entertainment, internet applications, and embodied intelligence.Over the past six months, Tripo AI has released a series of advanced 3D foundation models, including Tripo H3.1 and Tripo P1.0, while introducing major algorithmic breakthroughs such as 8K Texture Generation and Segmentation V2. In independent blind evaluations and community voting, Tripo AI has consistently ranked among the world's top AI 3D models. The company also introduced Project Eden, its world model research preview, pioneering native architecture that decouples underlying state simulation from visual rendering and establishing a new paradigm for world model development.Following the completion of this round, Tripo AI will further increase investment in 3D foundation models and world models, with a focus on core algorithm development, data infrastructure, and the recruitment of top global talent. The company will also accelerate its global commercialization and strengthen its industry ecosystem, reinforcing its technology and product leadership while delivering more powerful AI solutions to creators and enterprise customers worldwide.About Tripo AITripo AI is a globally leading general artificial intelligence company, dedicated to building next-generation interactive content creation capabilities for the mass market, powered by its proprietary AI 3D foundation models and world models. Its mission is to democratize creativity at scale and ultimately establish an interactive world content platform.The company has developed a comprehensive end-to-end product ecosystem, built around its proprietary 3D foundation models and world models, along with ecosystem plugins and an integrated all-in-one workspace. Backed by a world-class AI research team and a vast repository of high-quality spatial assets, Tripo AI is advancing AI toward true spatial understanding, physical simulation, and real-world production.Tripo AI’s models and products have been widely adopted by individual users and enterprises globally, serving industries including intelligent manufacturing, virtual reality, interactive entertainment, and embodied AI, empowering enterprises to unlock new productivity and accelerate real-world applications at scale.

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AeroVironment, Inc. (“AeroVironment” or “the Company”) (NASDAQ: AVAV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Badger Meter, Inc. (“Badger” or “the Company”) (NYSE: BMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

BERKELEY, California, July 02, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a one-for-twenty-five (1:25) reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on July 7, 2026, and the Company’s common stock will open for trading on The Nasdaq Global Market on July 7, 2026 on a post-split basis, under the existing ticker symbol “PFSA” but with a new CUSIP number 74319X 306.

NEW YORK, July 02, 2026 (GLOBE NEWSWIRE) -- Morpho, a creator-focused hardware innovation company, announced the launch of its flagship desktop UV printing system, built around a simple vision: the ultimate desktop UV printer today, expandable for endless possibilities tomorrow. Designed to transform how artists, Etsy sellers, makers, and small businesses approach object personalization, Morpho strips away the complexity and heavy maintenance of traditional industrial equipment, repackaging professional-grade fabrication into an approachable, desktop-friendly creative tool.

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) --  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veritone, Inc. (“Veritone” or “the Company”) (NASDAQ: VERI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, July 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.